BTIG analyst Kambiz Yazdi reiterated a Buy rating and $843.00 price target on Praxis Precision Medicines Inc. (NASDAQ: PRAX)The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments